Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > VCYT Veracyte > Detailed Quotes

VCYT Veracyte

17.090
+0.490+2.95%
Close 10/03 16:00 ET
High
17.470
Open
17.100
Turnover
15.59M
Low
16.410
Pre Close
16.600
Volume
912.10K
Market Cap
1.22B
P/E(TTM)
Loss
52wk High
54.130
Shares
71.58M
P/E(Static)
Loss
52wk Low
14.850
Float Cap
1.15B
Bid/Ask %
0.00%
Historical High
86.030
Shs Float
67.44M
Volume Ratio
0.72
Historical Low
4.210
Dividend TTM
--
Div Yield TTM
--
P/B
1.15
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.35%
Amplitude
6.39%
Avg Price
17.093
Lot Size
1
Float Cap
1.15B
Bid/Ask %
0.00%
Historical High
86.030
Shs Float
67.44M
Volume Ratio
0.72
Historical Low
4.210
Dividend TTM
--
P/B
1.15
Dividend LFY
--
Turnover Ratio
1.35%
Amplitude
6.39%
Avg Price
17.093
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.
CEO: Mr. Marc A. Stapley
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...